Plants have been the source of a variety of medicines for centuries. With the advent of modern medicines, the plant-based products are distinguished as traditional medicines in Asia and simply as herbals elsewhere. Today they are prepared with sophisticated processes and offered in the form of tablets and capsules and liquids, their appearance barely distinguishable from their modern cousins.
While herbals are gaining increasing popularity worldwide, primarily due to the consumer or the patient's desire to reduce reliance on pharmaceuticals, only a small number of them have been proven to be clinically effective. The vast majority are either untested or at best inconclusive in terms of their therapeutic value; and a number of them have been clinically rejected by the medical community as bearing no benefit other than a placebo effect.
Paradigm's portfolio consists of those herbals that are supported by clinical data, or reliable scientific evidence, or sufficient empirical evidence as to their value to the consumer from the market data. Still, the herbals lacking the sort of rigorous clinical data that is required of a modern medicine we hope that continued scientific scrutiny would either validate a particular product in our portfolio or cause us to eliminate it from our offerings.
Meanwhile, we ensure that every herbal product in our portfolio is manufactured in a plant accredited by the health authroties for Good Manufcturing Practice (GMP), and that each product is backed up by a Certificate of Analysis (COA) approved by a Food and Drug Authority for the product quality and safety.